Table 4.
Factors | N | PTEN Expression | mTOR Expression | p-mTOR Expression | P70S6K1 Expression | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Low | High | P | Low | High | P | Low | High | P | Low | High | P | ||
Age, years | .198 | .788 | .989 | .888 | |||||||||
≤60 | 78 | 49 | 29 | 39 | 39 | 36 | 42 | 41 | 37 | ||||
>60 | 67 | 35 | 32 | 35 | 32 | 31 | 36 | 36 | 31 | ||||
Sex | .360 | .518 | .025 | .420 | |||||||||
Male | 111 | 62 | 49 | 55 | 56 | 57 | 54 | 61 | 50 | ||||
Female | 34 | 22 | 12 | 19 | 15 | 10 | 24 | 16 | 18 | ||||
Tumor length | .185 | .447 | .008 | .005 | |||||||||
<3 cm | 37 | 18 | 19 | 23 | 14 | 24 | 13 | 27 | 10 | ||||
≥3 cm | 108 | 66 | 42 | 51 | 57 | 43 | 65 | 50 | 58 | ||||
Differentiation | .100 | .282 | .059 | .160 | |||||||||
Well | 17 | 9 | 8 | 10 | 7 | 9 | 8 | 12 | 5 | ||||
Moderately | 90 | 54 | 36 | 52 | 38 | 47 | 43 | 44 | 46 | ||||
Poorly | 38 | 21 | 17 | 12 | 26 | 11 | 27 | 21 | 17 | ||||
T stage | .001 | .308 | .422 | .003 | |||||||||
T1 | 13 | 4 | 9 | 9 | 4 | 8 | 5 | 9 | 4 | ||||
T2 | 34 | 12 | 22 | 16 | 18 | 18 | 16 | 23 | 11 | ||||
T3 | 64 | 42 | 22 | 35 | 29 | 26 | 38 | 40 | 24 | ||||
T4 | 34 | 26 | 8 | 14 | 20 | 15 | 19 | 10 | 24 | ||||
N stage | .003 | .026 | .002 | .000 | |||||||||
N0 | 55 | 24 | 31 | 35 | 20 | 36 | 19 | 39 | 16 | ||||
N1 | 55 | 31 | 24 | 28 | 27 | 22 | 33 | 31 | 24 | ||||
N2 | 30 | 25 | 5 | 9 | 21 | 8 | 22 | 4 | 26 | ||||
N3 | 5 | 4 | 1 | 2 | 3 | 1 | 4 | 3 | 2 | ||||
TNM stage | .017 | .022 | .010 | .028 | |||||||||
I | 12 | 3 | 9 | 9 | 3 | 8 | 4 | 10 | 2 | ||||
II | 53 | 28 | 25 | 32 | 21 | 31 | 22 | 31 | 22 | ||||
III + IV | 80 | 53 | 27 | 33 | 47 | 28 | 52 | 36 | 44 | ||||
PTEN | .085 | .000 | |||||||||||
Low | 84 | – | – | – | 48 | 36 | – | – | – | 25 | 59 | ||
High | 61 | – | – | 26 | 35 | – | – | 52 | 9 | ||||
p-AKT | .000 | .036 | .071 | .000 | |||||||||
Low | 77 | 36 | 41 | 33 | 44 | 41 | 36 | 52 | 25 | ||||
High | 68 | 48 | 20 | 41 | 27 | 26 | 42 | 25 | 43 | ||||
p-mTOR | .544 | .000 | .601 | ||||||||||
Low | 67 | 37 | 30 | 45 | 22 | – | – | – | 34 | 33 | |||
High | 78 | 47 | 31 | 29 | 49 | – | – | 43 | 35 | ||||
p-4E-BP1 | .088 | .056 | .992 | .000 | |||||||||
Low | 93 | 49 | 44 | 53 | 40 | 43 | 50 | 61 | 32 | ||||
High | 52 | 35 | 17 | 21 | 31 | 24 | 28 | 16 | 36 | ||||
p-P70S6K1 | .019 | .167 | .272 | .000 | |||||||||
Low | 86 | 43 | 43 | 48 | 38 | 43 | 43 | 57 | 29 | ||||
High | 59 | 41 | 18 | 26 | 33 | 24 | 35 | 20 | 39 |
Abbreviations: mTOR, mammalian target of rapamycin; P70S6K1, P70S6 kinase 1; PTEN, phosphatase and tensin homolog. Bold values mean significant difference.